[EN] COMPOUNDS FOR TREATMENT OF CYSTIC FIBROSIS<br/>[FR] COMPOSÉS DESTINÉS AU TRAITEMENT DE LA MUCOSVISCIDOSE
申请人:CALIFORNIA INST BIOMEDICAL RES
公开号:WO2015003083A1
公开(公告)日:2015-01-08
Described herein are compounds, compositions, and methods of their use for the treatment of cystic fibrosis.
本文描述了用于治疗囊性纤维化的化合物、组合物及其使用方法。
MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF
申请人:THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH
公开号:US20160317623A1
公开(公告)日:2016-11-03
Methods and compositions are provided for extending the half-life of a therapeutic agent. A modified therapeutic agent (mTA) comprises a therapeutic agent, a staple, and a half-life extending molecule. The mTAs disclosed herein may be used to treat a disease or a condition in a subject in need thereof.
ELASTASE INHIBITORS
申请人:The California Institute for Biomedical Research
公开号:US20170144998A1
公开(公告)日:2017-05-25
Described herein are compounds, compositions, and methods of their use for the treatment of a lung or intestinal disease.